(Q38219737)

31 August 2017

Delamanid: first global approval (English)

1 reference

31 August 2017

1 reference

Nicola J Ryan

1

1 reference

PubMed ID

24923253

31 August 2017

Jin Han Lo

series ordinal

2

1 reference

31 August 2017

1 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

74

1 reference

31 August 2017

9

1 reference

31 August 2017

1041-1045

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-014-0241-5

31 August 2017

0 references

cites work

New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Drugs in development for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

New treatment options for multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Tuberculosis: the drug development pipeline at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Delamanid for multidrug-resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0241-5

Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24923253

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40265-014-0241-5

1 reference

PubMed ID

24923253

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

24923253